[1] HILLEMANNS P,SOERGEL P,HERTEL H,et al.Epidemiology and early detection of cervical cancer［J］.Oncol Res Treat,2016,39(9):501-506.
[2] TSIKOURAS P,ZERVOUDIS S,MANAV B,et al.Cervical cancer:screening,diagnosis and staging［J］.J BUON,2016,21(2):320-325.
[3] KREIMER AR,SCHIFFMAN M,HERRERO R,et al.Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment［J］.Int J Cancer,2012,131(1):211-218.
[4] HONKE N,SHAABANI N,ZHANG DE,et al.Multiple functions of USP18［J］.Cell Death Dis,2016,7(11):e2444.
[5] ANJA BASTERS,KLAUS PETER KNOBELOCH,GUNTER FRITZ.USP18-a multifunctional component in the interferon response［J］.Biosci Rep,2018,38(6):BSR20180250.
[6] MALAKHVA OA，KIM KI，LUO JK，et al． UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptid-ase activity［J］．EMBO J,2006,25(11):2358－2367．
[7] YAN M,LUO JK,RITCHIE KJ,et al． Ubp43 regulates BCR－ABL leukemogenesis via the type 1 interferon receptor signaling［J］．Blood,2007,110(1):305－312．
[8] GUO Y,CHINYENGETERE F,DOLINKO AV,et al．Evidence for the ubiquitin protease UBP43 as an an-tineoplastic target［J］．Mol Cancer Ther，2012，11(9):1968－1977．
[9] HONG B,LI H,LU Y,et al． USP18 is crucial for IFN－γ－mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity［J］．Mol Cancer,2014,13(1):1-12．
[10] VUILLIER F,LI Z,COMMERE PH,et al.USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression［J］.Sci Rep,2019,9(1):4066.
[11] TAN Y,ZHOU G,WANG X,et al.USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway［J］.Int J Oncol,2018,53(1):371-383.
[12] BIDWELL BN,SLANEY CY,WITHANA NP,et al． Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape［J］.Nat Med,2012,18(8):1224－1231．
[13] JEON YJ,JO MG,YOO HM,et al． Chemosensitivity is controlled by p63 modification with ubiquitin－like protein ISG15 ［J］．J Clin Invest，2012，122(7):2622－2636．
[14] ANJA B,KLAUS-PETER K,GUNTER F.USP18-a multifunctional component in the interferon response［J］.Biosci Rep，2018,38(6):BSR20180250.
[15] TONG HV,HOAN NX,BINH MT，et al．Upregulation of enzymes involved in ISGylation and Ubiquitination in patients with hepatocellular carcinoma［J］.Int J Med Sci,2020,17(3):347-353.
[16] HUANG F,ZHENG C,HUANG L,et al． USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer［J］.Cancer Cell Int,2020,28(20):346.
[17] FENG L,WANG K,TANG P,et al．Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis［J］.Aging(Albany NY)，2020,12(19):19273-19292.
[18] XIKUI LIU,HONGXIU LI,BO ZHONG,et al．USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex［J］． Exp Med,2013,210(8):1575-1590.
[19] SANTIN I,MOORE F,GRIECO FA,et al．USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis［J］.Cell Death Dis,2012,3(11):e419.